Published on October 23rd, 2013 | by nda0
Are you attending ISPOR 16th Annual European Congress in Dublin on 2-6 November?
NDAs Dr. Thomas Lonngren, regulatory affairs, HTA expert and former head of the EMA, will be attending to talk how companies can best address the challenges and opportunities presented by the new EU pharmacovigilance requirements of the regulators, the assessor, need for real-world evaluation, and the payers needs to demonstrate value. The session will be held in conjunction with Shelley Gandhi, head of pharmacovigilance for NDA, formerly from MHRA. It takes place on Tuesday 5th November between 3-4pm.
If you are interested in meeting Dr. Lonngren or Shelley Gandhi to discuss the issues they raise in more detail, please contact Paula Warmer on email@example.com.